What is a good titration schedule for Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lexapro (Escitalopram) Titration Schedule

Start escitalopram at 10 mg once daily and maintain this dose for at least 1 week in adults (3 weeks in adolescents) before considering dose escalation to 20 mg daily if needed. 1

Initial Dosing

  • Adults with Major Depressive Disorder or Generalized Anxiety Disorder: Begin with 10 mg once daily, taken in the morning or evening with or without food 1
  • Adolescents (12-17 years) with Major Depressive Disorder: Start with 10 mg once daily 1
  • Elderly patients and those with hepatic impairment: Use 10 mg/day as the maximum recommended dose without titration 1

Dose Escalation Timeline

  • Adults: If increasing to 20 mg/day, wait a minimum of 1 week at the 10 mg dose before escalating 1
  • Adolescents: If increasing to 20 mg/day, wait a minimum of 3 weeks at the 10 mg dose before escalating 1
  • Fixed-dose trials demonstrated effectiveness of both 10 mg and 20 mg in adults, though 20 mg did not show greater benefit than 10 mg for major depression 1

Important Considerations During Titration

  • Early response assessment: Escitalopram demonstrates significant superiority over placebo as early as week 1 of treatment 2, with therapeutic effects potentially visible within the first week 3
  • Common side effects during initial titration: Nausea (occurring in >10% of patients), insomnia, diarrhea, dry mouth, and somnolence are most common early in treatment 2
  • Steady-state concentrations: Achieved within 7-10 days of administration due to the 27-33 hour elimination half-life 4

Special Populations

  • Severe renal impairment: Use with caution; no specific dose adjustment provided but careful monitoring warranted 1
  • Mild to moderate renal impairment: No dosage adjustment necessary 1

Discontinuation Protocol

  • Gradual taper required: Reduce dose gradually rather than stopping abruptly to minimize discontinuation symptoms 1
  • If intolerable symptoms occur during taper, resume the previous dose and decrease more slowly 1

Screening Before Initiation

  • Bipolar disorder screening mandatory: Assess personal and family history of bipolar disorder, mania, or hypomania before starting treatment to avoid precipitating manic episodes 1

Drug Interactions During Titration

  • MAOI washout period: Allow at least 14 days between discontinuing an MAOI and starting escitalopram 1
  • Minimal cytochrome P450 enzyme effects suggest low potential for drug-drug interactions 4

References

Research

Escitalopram.

Expert opinion on investigational drugs, 2002

Research

The clinical pharmacokinetics of escitalopram.

Clinical pharmacokinetics, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.